State-wise Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Southern States of India (As on 25.07.2021) | |||
States/UTs | Remdesivir | Tocilizumab | Amphotericin B |
Andhra Pradesh | |||
Karnataka | |||
Kerala | |||
Lakshadweep | |||
Puducherry | |||
Tamil Nadu | |||
Telangana | |||
Southern States | |||
India |